Pictet Asset Management (UK)’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$140K Sell
34,600
-266,430
-89% -$1.04M ﹤0.01% 1677
2021
Q1
$1.29M Buy
301,030
+86,729
+40% +$414K ﹤0.01% 1024
2020
Q4
$846K Hold
214,301
﹤0.01% 1048
2020
Q3
$791K Buy
214,301
+194,701
+993% +$822K ﹤0.01% 993
2020
Q2
$67K Buy
+19,600
New +$43.9K ﹤0.01% 1121
2019
Q2
Sell
-696,000
Closed -$1.82M 1040
2019
Q1
$1.82M Buy
696,000
+205,600
+42% +$623K ﹤0.01% 867
2018
Q4
$1.48K Buy
490,400
+95,700
+24% +$324K ﹤0.01% 862
2018
Q3
$1.37M Sell
394,700
-16,600
-4% -$88.1K ﹤0.01% 913
2018
Q2
$1.93M Sell
411,300
-69,800
-15% -$265K ﹤0.01% 807
2018
Q1
$1.52M Buy
481,100
+199,100
+71% +$802K ﹤0.01% 813
2017
Q4
$1.38M Buy
282,000
+94,600
+50% +$549K ﹤0.01% 822
2017
Q3
$1.29M Buy
+187,400
New +$1.18M ﹤0.01% 819

Other funds holding OPK

Pictet Asset Management (UK)'s OPK Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Opko Health (OPK) stake by 89% in Q2 2021, selling an estimated $1.04M and leaving 34,600 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #1677.

Pictet Asset Management (UK) first reported a position in OPK in Q3 2017 and has held it in 12 quarters since. The position peaked at $1.93M in Q2 2018. 233 funds tracked by Wall St. Rank hold OPK as of Q2 2021.

  • Pictet Asset Management (UK) held 34,600 shares of Opko Health worth $140K as of Q2 2021.
  • Pictet Asset Management (UK) sold 266,430 Opko Health shares in Q2 2021, an estimated $1.04M.
  • Opko Health made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1677 holding.
  • Pictet Asset Management (UK) first reported a position in Opko Health in Q3 2017 and has held it in 12 quarters since.
  • Pictet Asset Management (UK)'s Opko Health position peaked at $1.93M in Q2 2018.
  • 233 funds tracked by Wall St. Rank held Opko Health as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.